| 摘要 |
<p>The invention concerns the use of an immunogenic agent derived from Helicobacter, associated with an adjuvant such as QS-21, DC-chol or Bay R1005, for making a pharmaceutical composition designed to induce an immune response of the T helper 1 type (Th1), for preventing or treating Helicobacter infection in a mammal.</p> |
